SILEXION THERAPEUTICS CORP Payment for Debt Extinguishment or Debt Prepayment Cost
SILEXION THERAPEUTICS CORP (SLXN) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $551.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2025-08-12
- SILEXION THERAPEUTICS CORP payment for debt extinguishment or debt prepayment cost for the quarter ending 2025-06-30 was $0.00.
- SILEXION THERAPEUTICS CORP payment for debt extinguishment or debt prepayment cost for the quarter ending 2025-03-31 was $551.00K.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month |
|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $551.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $551.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |